Delivery Order SPE2DB22D3301-SPE2DB24FZ3HV

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,695.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to control serum phosphorus levels in adult patients with chronic kidney disease on dialysis. The contract is not designated as a set-aside and represents a task order under a larger $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat high phosphorus levels in adult patients with chronic kidney disease on dialysis. The delivery order has a firm fixed price ceiling value of $7,164.90 and a performance period ending on June 24, 2025. It is not designated as a set-aside contract....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,004.74, is for the provision of Velphoro 500 mg chewable tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,185.54 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat high phosphorus levels in patients with chronic kidney disease on dialysis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $8,006.42 and runs through January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,105.51 delivery order contract is for the supply of Velphoro 500 mg chewable tablets, a medication used for the treatment of hyperphosphatemia. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,269.20 Firm Fixed Price Delivery Order contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to manage high phosphorus levels in patients with chronic kidney disease on dialysis. The contract has a completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Velphoro 500 MG Chewable Tablets in 90-count packages, with a ceiling value of $1,992.86 and an ultimate completion date of May 30, 2025. The contract is not set-aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Velphoro 500 mg chewable tablets, with a ceiling value of $20,369.01 and a performance period through November 15, 2023. This award is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,882.86, is for the delivery of Velphoro 500 mg chewable tablets. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3HV
    Delivery Order

This is a $6,306.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat hyperphosphatemia in chronic kidney disease patients. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 21, 2024.

Generated 11/19/24, 9:22 AM